Drugs / 16.ALPHA.-BROMOEPIANDROSTERONE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00002422 | — | HIV infectious disease | Harbor Therapeutics | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 16.ALPHA.-BROMOEPIANDROSTERONE | ChEMBL registry synonym — accepted as the source's own label CHEMBL445472 ↗ |
| Known as | Alpha-Epi-Br | “A Phase I/II, Open-Label Study of the Safety, Tolerance, Pharmacokinetics, Drug-Interaction and Anti-HIV Activity of Intramuscularly Administered Alpha-Epi-Br (HE2000) in...” NCT00002422 ↗ |
| Known as | HE2000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002422 ↗ |
| Modality | Small molecule | “HE2000 is a synthetic steroid hormone” NCT00002422 ↗ |
| Route | Intramuscular | “intramuscularly” NCT00002422 ↗ |